Age, Biography and Wiki

John David Spence was born on 10 November, 1944 in Peru, Talara. Discover John David Spence's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 79 years old?

Popular As N/A
Occupation Neurologist, Internist and Clinical Pharmacologist
Age 80 years old
Zodiac Sign Scorpio
Born 10 November, 1944
Birthday 10 November
Birthplace Peru, Talara
Nationality Peru

We recommend you to check the complete list of Famous People born on 10 November. He is a member of famous with the age 80 years old group.

John David Spence Height, Weight & Measurements

At 80 years old, John David Spence height not available right now. We will update John David Spence's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

John David Spence Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is John David Spence worth at the age of 80 years old? John David Spence’s income source is mostly from being a successful . He is from Peru. We have estimated John David Spence's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

John David Spence Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2018

Effects of the intestinal microbiome on atherosclerosis He reported with colleagues in 2018 that patients with carotid atherosclerosis not explained by traditional risk factors had higher blood levels of toxic metabolites produced by intestinal bacteria from foods such as red meat and egg yolk. His group also found that blood levels of those toxic products are elevated with even moderate impairment of kidney function, such as seen in elderly patients. This has important implications for diet, and offers the possibility of an entirely new way of treating atherosclerosis: repopulation of the intestinal microbiome.

2017

Physiologically individualized therapy for resistant hypertension. Reported in 2017 that in patients in three hypertension clinics in Africa, measuring plasma renin activity and aldosterone markedly improved blood pressure control, but permitting selection of the treatment that is appropriate to that patient, by identifying the physiological cause of the hypertension.

2005

Appropriate carotid endarterectomy: Showed in 2005 () that with intensive medical therapy most patients with asymptomatic carotid stenosis cannot benefit from endarterectomy or stenting, and that the very small proportion (10%) who may benefit can be identified by microembolus detection on transcranial Doppler. Showed in 2010 () that the proportion who could benefit had declined with more intensive therapy to less than 5%. SPARC's work was confirmed in 2010 by an international multicenter study, the ACES study. Dr. Spence led a study in the Canadian Atherosclerosis Imaging Network, on histological validation of imaging features of vulnerable plaque that will also serve to identify high-risk carotid plaques.

1990

Ultrasound measurement of plaque: Beginning in 1990, Dr. Spence pioneered the use of carotid plaque measurement (as opposed to intima-media thickness) for research and for management of patients with carotid artery disease. (.). This has evolved to the use of 3-D plaque volume measurements for evaluation of new therapies. The effect of drug therapies on carotid plaque volume can now be evaluated in a very cost-effective way.

1976

Effects of antihypertensive drugs on blood velocity and arterial flow disturbances 1976, 1980, 1995: these studies showed that antihypertensive drugs have different effects on blood velocity and arterial flow disturbances, which have implications for how effective they are at fighting the buildup of arterial plaque. (.)

1944

John David Spence CM (born November 10, 1944) is a Canadian medical doctor, medical researcher and professor at the University of Western Ontario. Along with his affiliation with the University of Western Ontario (where he teaches Clinical Neurological Science) he is affiliated with the London Health Sciences Centre's University Hospital (where he has set up and runs stroke prevention clinics) and the Robarts Research Institute, one of Canada's leading medical research organizations. He is a recognized expert in stroke prevention and stroke prevention research and has over 500 peer-reviewed publications since 1970. He has delivered more than 600 lectures in 38 countries to physicians around the world. In 2015, he received the Research Excellence Award from the Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology. In 2019, he was appointed a Member of the Order of Canada.